---

Recent advances in treatment of breast cancers

---

Review Article

Author Details : A.G. Nerkar*

Volume : 4, Issue : 2, Year : 2022

Article Page : 67-74

https://doi.org/10.18231/j.ctppc.2022.013

Suggest article by email

Get Permission

---

Abstract

Growth factors receptors and hormones play an important role several cell minor cell types.With advent of advancement in Breast cancer (BC) treatment and therapies ther of there has been major advancement in this area after this discovery. The combined sciences of cellular biology and therapeutic fields have made the breast cancer a seized cure area for discoveries of new therapies and its design including the heterogeneity. This article reviews the numerous prospective innovative therapies for targeting major cell subtypes of BC cells, as well as the present therapeutic regimens. In the personalised BC drug, speedy scientific advancement of poly inhibitors (ADP-ribose) polymerase, cyclin-dependent kinases four and six, phosphatidylinositol 3-kinase / protein kinase b / mammalian target rapamycin pathway, histone deacetylation, multi-concentrated in tyrosine kinases, as well as antibodies. The Triple negative breast cancer (TNBC) has been the most challenging area for design of therapies and for drug discovery. For TNBC, as such there is no approved treatment and it is most dangerous type of BC. The article also discusses the TNBC heterogeneity and TNBC molecular subtyping. It could also help find medications to treat this terrible disease. The cell proliferation and propagation inhibitors for treatment-resistant strains also puts the invention of targets for small molecules of BC in concern.

Keywords: Breast cancer, Inhibitors of cyclin-dependent kinases 4 and 6, Hormone receptor, Human epidermal growth factor receptor 2, Poly (ADP-ribose) polymerase inhibitor

How to cite : Nerkar A, Recent advances in treatment of breast cancers. Curr Trends Pharm Pharm Chem 2022;4(2):67-74

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.